Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users

Amy Knowlton, Julia Arnsten, Lois Eldred, James Wilkinson, Marc Gourevitch, Starley Shade, Krista Dowling, David Purcell

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Among individuals receiving highly active antiretroviral therapy (HAART), injection drug users (IDUs) are less likely to achieve HIV suppression. The present study examined individual-level, interpersonal, and structural factors associated with achieving undetectable plasma viral load (UVL) among US IDUs receiving recommended HAART. Data were from baseline assessments of the INSPIRE (Interventions for Seropositive Injectors-Research and Evaluation) study, a 4-site, secondary HIV prevention intervention for heterosexually active IDUs. Of 1113 study participants at baseline, 42% (n = 466) were currently taking recommended HAART (34% were female, 69% non-Hispanic black, 26% recently homeless; median age was 43 years), of whom 132 (28%) had a UVL. Logistic regression revealed that among those on recommended HAART, adjusted odds of UVL were at least 3 times higher among those with high social support, stable housing, and CD4 > 200; UVL was approximately 60% higher among those reporting better patient-provider communication. Outpatient drug treatment and non-Hispanic black race and an interaction between current drug use and social support were marginally negatively significant. Among those with high perceived support, noncurrent drug users compared with current drug users had a greater likelihood of UVL; current drug use was not associated with UVL among those with low support. Depressive symptoms (Brief Symptom Inventory) were not significant. Results suggest the major role of social support in facilitating effective HAART use in this population and suggest that active drug use may interfere with HAART use by adversely affecting social support. Interventions promoting social support functioning, patient-provider communication, stable housing, and drug abuse treatment may facilitate effective HAART use in this vulnerable population.

Original languageEnglish
Pages (from-to)486-492
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes
Volume41
Issue number4
DOIs
StatePublished - Apr 1 2006

Fingerprint

Highly Active Antiretroviral Therapy
Drug Users
Viral Load
Social Support
Injections
Pharmaceutical Preparations
Communication
HIV
Vulnerable Populations
Secondary Prevention
Substance-Related Disorders
Outpatients
Logistic Models
Depression
Equipment and Supplies
Therapeutics
Research
Population

Keywords

  • African American
  • Antiretroviral effectiveness
  • HIV/AIDS
  • Illicit injection drug users
  • Patient-provider communication
  • Social support
  • Stable housing

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. / Knowlton, Amy; Arnsten, Julia; Eldred, Lois; Wilkinson, James; Gourevitch, Marc; Shade, Starley; Dowling, Krista; Purcell, David.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 41, No. 4, 01.04.2006, p. 486-492.

Research output: Contribution to journalArticle

Knowlton, Amy ; Arnsten, Julia ; Eldred, Lois ; Wilkinson, James ; Gourevitch, Marc ; Shade, Starley ; Dowling, Krista ; Purcell, David. / Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. In: Journal of Acquired Immune Deficiency Syndromes. 2006 ; Vol. 41, No. 4. pp. 486-492.
@article{63e8b66d741d4e48b75357f970d51e1f,
title = "Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users",
abstract = "Among individuals receiving highly active antiretroviral therapy (HAART), injection drug users (IDUs) are less likely to achieve HIV suppression. The present study examined individual-level, interpersonal, and structural factors associated with achieving undetectable plasma viral load (UVL) among US IDUs receiving recommended HAART. Data were from baseline assessments of the INSPIRE (Interventions for Seropositive Injectors-Research and Evaluation) study, a 4-site, secondary HIV prevention intervention for heterosexually active IDUs. Of 1113 study participants at baseline, 42{\%} (n = 466) were currently taking recommended HAART (34{\%} were female, 69{\%} non-Hispanic black, 26{\%} recently homeless; median age was 43 years), of whom 132 (28{\%}) had a UVL. Logistic regression revealed that among those on recommended HAART, adjusted odds of UVL were at least 3 times higher among those with high social support, stable housing, and CD4 > 200; UVL was approximately 60{\%} higher among those reporting better patient-provider communication. Outpatient drug treatment and non-Hispanic black race and an interaction between current drug use and social support were marginally negatively significant. Among those with high perceived support, noncurrent drug users compared with current drug users had a greater likelihood of UVL; current drug use was not associated with UVL among those with low support. Depressive symptoms (Brief Symptom Inventory) were not significant. Results suggest the major role of social support in facilitating effective HAART use in this population and suggest that active drug use may interfere with HAART use by adversely affecting social support. Interventions promoting social support functioning, patient-provider communication, stable housing, and drug abuse treatment may facilitate effective HAART use in this vulnerable population.",
keywords = "African American, Antiretroviral effectiveness, HIV/AIDS, Illicit injection drug users, Patient-provider communication, Social support, Stable housing",
author = "Amy Knowlton and Julia Arnsten and Lois Eldred and James Wilkinson and Marc Gourevitch and Starley Shade and Krista Dowling and David Purcell",
year = "2006",
month = "4",
day = "1",
doi = "10.1097/01.qai.0000186392.26334.e3",
language = "English",
volume = "41",
pages = "486--492",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "4",

}

TY - JOUR

T1 - Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users

AU - Knowlton, Amy

AU - Arnsten, Julia

AU - Eldred, Lois

AU - Wilkinson, James

AU - Gourevitch, Marc

AU - Shade, Starley

AU - Dowling, Krista

AU - Purcell, David

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Among individuals receiving highly active antiretroviral therapy (HAART), injection drug users (IDUs) are less likely to achieve HIV suppression. The present study examined individual-level, interpersonal, and structural factors associated with achieving undetectable plasma viral load (UVL) among US IDUs receiving recommended HAART. Data were from baseline assessments of the INSPIRE (Interventions for Seropositive Injectors-Research and Evaluation) study, a 4-site, secondary HIV prevention intervention for heterosexually active IDUs. Of 1113 study participants at baseline, 42% (n = 466) were currently taking recommended HAART (34% were female, 69% non-Hispanic black, 26% recently homeless; median age was 43 years), of whom 132 (28%) had a UVL. Logistic regression revealed that among those on recommended HAART, adjusted odds of UVL were at least 3 times higher among those with high social support, stable housing, and CD4 > 200; UVL was approximately 60% higher among those reporting better patient-provider communication. Outpatient drug treatment and non-Hispanic black race and an interaction between current drug use and social support were marginally negatively significant. Among those with high perceived support, noncurrent drug users compared with current drug users had a greater likelihood of UVL; current drug use was not associated with UVL among those with low support. Depressive symptoms (Brief Symptom Inventory) were not significant. Results suggest the major role of social support in facilitating effective HAART use in this population and suggest that active drug use may interfere with HAART use by adversely affecting social support. Interventions promoting social support functioning, patient-provider communication, stable housing, and drug abuse treatment may facilitate effective HAART use in this vulnerable population.

AB - Among individuals receiving highly active antiretroviral therapy (HAART), injection drug users (IDUs) are less likely to achieve HIV suppression. The present study examined individual-level, interpersonal, and structural factors associated with achieving undetectable plasma viral load (UVL) among US IDUs receiving recommended HAART. Data were from baseline assessments of the INSPIRE (Interventions for Seropositive Injectors-Research and Evaluation) study, a 4-site, secondary HIV prevention intervention for heterosexually active IDUs. Of 1113 study participants at baseline, 42% (n = 466) were currently taking recommended HAART (34% were female, 69% non-Hispanic black, 26% recently homeless; median age was 43 years), of whom 132 (28%) had a UVL. Logistic regression revealed that among those on recommended HAART, adjusted odds of UVL were at least 3 times higher among those with high social support, stable housing, and CD4 > 200; UVL was approximately 60% higher among those reporting better patient-provider communication. Outpatient drug treatment and non-Hispanic black race and an interaction between current drug use and social support were marginally negatively significant. Among those with high perceived support, noncurrent drug users compared with current drug users had a greater likelihood of UVL; current drug use was not associated with UVL among those with low support. Depressive symptoms (Brief Symptom Inventory) were not significant. Results suggest the major role of social support in facilitating effective HAART use in this population and suggest that active drug use may interfere with HAART use by adversely affecting social support. Interventions promoting social support functioning, patient-provider communication, stable housing, and drug abuse treatment may facilitate effective HAART use in this vulnerable population.

KW - African American

KW - Antiretroviral effectiveness

KW - HIV/AIDS

KW - Illicit injection drug users

KW - Patient-provider communication

KW - Social support

KW - Stable housing

UR - http://www.scopus.com/inward/record.url?scp=33646812584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646812584&partnerID=8YFLogxK

U2 - 10.1097/01.qai.0000186392.26334.e3

DO - 10.1097/01.qai.0000186392.26334.e3

M3 - Article

VL - 41

SP - 486

EP - 492

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

SN - 1525-4135

IS - 4

ER -